{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifqebwyzjsm7j7mo3gcw2lwmkwmrk6uc3svqm7w65sqvpayogwuci",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mooozc54tar2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih3m3qavp3ddenagsufs6zc2f3n2qxjqvpu7du6rfnscxsqftwgk4"
    },
    "mimeType": "image/jpeg",
    "size": 64307
  },
  "path": "/news/2026-06-fda-counter-naloxone-nasal-spray.html",
  "publishedAt": "2026-06-19T20:00:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone hydrochloride), for the emergency treatment of opioid overdose. The nonprescription approval was granted to Amphastar Pharmaceuticals.",
  "title": "FDA approves another over-the-counter naloxone nasal spray"
}